Your Feed

Filter by
See content from
Back to the latest
Thumbnail for Promising Results with Elranatamab + Iberdomide from MagnetisMM-30| Attaya Suvannasankha, MD
Playlist: ASH 2025

Promising Results with Elranatamab + Iberdomide from MagnetisMM-30| Attaya Suvannasankha, MD

Video details & playlist
Thumbnail for The "No More MGUS" Project: Why It's Time to End "Undetermined" in MGUS | Bruno Paiva, PhD
Playlist: ASH 2025

The "No More MGUS" Project: Why It's Time to End "Undetermined" in MGUS | Bruno Paiva, PhD

Video details & playlist
Thumbnail for ReKInDLE study: Iberdomide Quadruplet Shows Promising Results | Benjamin Diamond, MD
Playlist: ASH 2025

ReKInDLE study: Iberdomide Quadruplet Shows Promising Results | Benjamin Diamond, MD

Video details & playlist
Thumbnail for IMMUNOPLANT-Will Linvoseltamab Consolidation Replace ASCT? | Dickran Kazandjian, MD
Playlist: ASH 2025

IMMUNOPLANT-Will Linvoseltamab Consolidation Replace ASCT? | Dickran Kazandjian, MD

Video details & playlist
I’m wondering if anyone has had a similar experience. Long story short, my HUP oncologist had concerns that my lambda light chain MM treatments (3 or 4 lines) ceased “working” (Diagnosed late Nov 2023) and suggested that I consider CAR-T, to which I agreed. In early Dec. 2025 a PT-CT Total Body Tumor Localization showed reactivation of former FDG avid lesions AND new ones (femur, sternum, rib). Report: extensively distributed FDG avid lytic lesions. I’m now in a “clinical whirlwind”: targeted radiation in a few weeks (I’ve completed “simulation” and tattooing); underwent apheresis on 12/04; and two surprise cavities hidden under caps to be repaired Jan 7th. All the while my lambda free light chains keep rising: (11/4=107mg/L; 11/13=123; 12/2=125; 12/11=140). I fear what they might be by Jan. 19 the date set for CAR-T infusion! Things keep changing, however. On Nov 11, I was told I’d remain on Dara/Carfilzomib which was “keeping things relatively stable which is good. I don't want you off all treatment for too long as I worry you'd progress.” Apparently the labs showed progression! And that plan changed one month later: on 12/11 Dara was dropped and Cytoxin added to Kyprolis, and dexamethasone jumped to 12 mg (another round @ 12 mg coming up on 12/19), after that back to 4 mg. I’m under the impression that I’ll be on Cytoxin/Kyprolis/dex (12/19; 12/26; 1/8) until lymphodepletion chemo (? fludarabine and cyclophosphamide (Flu/Cy), once a day for three consecutive days): 1/14/2026 - Chemo 1/15/2026 - Chemo 1/16/2026 - Chemo Two days off 1/19/2026 - Hospital admission for inpatient CAR-T infusion. Since 12/11 (first dose of Cytoxin) I’ve had diarrhea a few days. Hoping it doesn’t continue for the next month! Question: Are there any specific questions I should be asking my oncologist? (Whom I have great respect for and trust). It seems like such a whirlwind. Anyone have similar experiences? Thanks!
Thumbnail for Treating High Risk Smoldering Multiple Myeloma- Aquila Updates | Natalie Callander, MD
Playlist: ASH 2025

Treating High Risk Smoldering Multiple Myeloma- Aquila Updates | Natalie Callander, MD

Video details & playlist
Thumbnail for Your Voice Matters: The Power of Patient-Reported Outcomes in Myeloma | Fabio Efficace, PhD
Playlist: ASH 2025

Your Voice Matters: The Power of Patient-Reported Outcomes in Myeloma | Fabio Efficace, PhD

Video details & playlist
Thumbnail for Anito-cel (a BCMA CAR-T) : Shows No Cases of Delayed Neurotoxicity | Natalie Callander, MD
Playlist: ASH 2025

Anito-cel (a BCMA CAR-T) : Shows No Cases of Delayed Neurotoxicity | Natalie Callander, MD

Video details & playlist
Thumbnail for S100A8 -a new target to prevent T cell exhaustion BsAbs in myeloma | Adolfo Aleman, PhD
Playlist: ASH 2025

S100A8 -a new target to prevent T cell exhaustion BsAbs in myeloma | Adolfo Aleman, PhD

Video details & playlist
Thumbnail for Fewer Bone Marrow Biopsies? Using Blood & Whole Genome Sequencing | Chrissy Baker, MSc
Playlist: ASH 2025

Fewer Bone Marrow Biopsies? Using Blood & Whole Genome Sequencing | Chrissy Baker, MSc

Video details & playlist
Avatar
pinkAntelope
Multiple Myeloma Discussion • December 17
Talvey side effects
Recently began Talvey therapy and have experienced known side effects of skin peeling on palms and feet, Very dry mouth and loss of taste. Expecting those side effects to subside now that on every four week injection schedule. I recently noticed that one of my thumb nails is becoming loose from it’s bed. Anyone else identified this as a side effect?
Thumbnail for Making CAR-T Cells inside the body? inMMyCAR Trial Insights | Natalie Callander, MD
Playlist: ASH 2025

Making CAR-T Cells inside the body? inMMyCAR Trial Insights | Natalie Callander, MD

Video details & playlist
Thumbnail for Etentamig in patients with relapsed refractory amyloidosis | Rajshekhar Chakraborty, MD
Playlist: ASH 2025

Etentamig in patients with relapsed refractory amyloidosis | Rajshekhar Chakraborty, MD

Video details & playlist
Thumbnail for AI Using Multimodal Datasets to Predict Response to CAR-T Treatment | Ciara Freeman, MD, PhD
Playlist: ASH 2025

AI Using Multimodal Datasets to Predict Response to CAR-T Treatment | Ciara Freeman, MD, PhD

Video details & playlist
Thumbnail for Prophylactic Tocilizumab to Prevent CRS During Bispecific Step-up Dosing | Astrid Torpe, MD
Playlist: ASH 2025

Prophylactic Tocilizumab to Prevent CRS During Bispecific Step-up Dosing | Astrid Torpe, MD

Video details & playlist
Avatar
Suzukiviolin25
Multiple Myeloma Discussion • December 16
Dupixent injections to counter revlimid side effects
Has anyone used Dupixent injections to counter the rash and itchy scalp side effects from Revlimid? Dermatologist from MSK suggested this biological drug as opposed to staying on steroids (prednisone) for longer period. Curious to see how commonly this drug is used and if effective in this setting.